Turn Therapeutics Inc. Stock Price

NasdaqGM:TTRX Community·US$158.0m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

TTRX Share Price Performance

US$5.06

-1.94 (-27.71%)

US$5.06

-1.94 (-27.71%)

US$5.06

Sat, 18 Oct 25

Share PriceUS$5.06

TTRX Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Flawless balance sheet with very low risk.

2 Risks

0 Rewards

View Full Analysis

Turn Therapeutics Inc. Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: -0.091
: 0%
: 0%
: 0%

View Full Analysis

About TTRX

Founded: 2015
Employees: 2
CEO: Bradley Burnam
WebsiteView website: www.turntherapeutics.com

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.